Alliance Pharma Share News (APH)

Alliance Pharma Chair Cook to depart in 2023, LeCouilliard to replace

(Alliance News) - Alliance Pharma PLC said on Wednesday Chair David Cook is to step down next year in line with "good corporate governance".

UK shareholder meetings calendar - next 7 days

IN BRIEF: Alliance Pharma buys ScarAway brand from Perrigo

Alliance Pharma PLC - Chippenham, England-based distributor of consumer healthcare brands and prescription medicines - Says it acquires silicone-based scar treatment brand ScarAway from Perrigo Co PLC. Alliance Pharma also buys the rights to sell its scar treatment brand brand Kelo-cote in the US. Alliance Pharma pays USD19.4 million in cash from existing financial resources to Dublin, Ireland-based Perrigo for both assets.

Alliance Pharma upbeat on prospects for US acquisitions

(Sharecast News) - Alliance Pharma completed the acquisition of both 'ScarAway' - the largest silicone-based scar treatment brand in the US - and the rights to sell 'Kelo-cote' in the American retail consumer market in the US on Friday.

EARNINGS UPDATES: MP Evans dividend outlook bright; ScS share buyback

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Alliance Pharma reports 'strong' 2021 performance

(Sharecast News) - Alliance Pharma reported a "strong" operational and financial performance in its 2021 results on Tuesday, with underlying revenue up 23% on a see-through basis to £169.6m.

LONDON BROKER RATINGS: Bank of America says buy Experian and Intertek

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

IN BRIEF: Alliance Pharma in talks for acquisition of two US products

Alliance Pharma PLC - Chippenham, England-based distributor of consumer healthcare brands and prescription medicines - Confirms that it is in talks with an unnamed third party for the acquisition of two products in the US. Should an acquisition take place the aggregate payment would come up to USD20 million at the most.

UK earnings, trading statements calendar - next 7 days

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

CMA issues £35m in fines for illegal anti-nausea tablet supply arrangement

(Sharecast News) - The Competition and Markets Authority has fined several pharmaceutical and private equity firms over £35.0m for an illegal arrangement in the supply of important NHS prescription anti-nausea tablets.

UPDATE 2-Britain fines firms $47 mln over price surge for NHS nausea pill

* Fines relate to arrangements to prevent rival launch* CMA says prochlorperazine price jumped 700% in 4 years* Alliance, Advanz to appeal CMA decision (Adds Advanz statement, background)By Pushkala Aripaka and Priyanshi MandhanFeb 3 (Reuters) - Br...

LONDON BROKER RATINGS: Barclays lifts ITV and S4 Capital to Overweight

LONDON BROKER RATINGS: Barclays lifts ITV and S4 Capital to Overweight

Alliance Pharma set to top underlying profit expectations

(Sharecast News) - Alliance Pharma reported "strong" full-year growth in a trading update on Tuesday, with see-through revenue rising 23%, or 27% on a constant currency basis, to £169.6m.

Alliance Pharma earnings up on increased revenue, e-commerce activity

Alliance Pharma earnings up on increased revenue, e-commerce activity